Copyright
©The Author(s) 2022.
World J Clin Cases. Sep 6, 2022; 10(25): 8808-8815
Published online Sep 6, 2022. doi: 10.12998/wjcc.v10.i25.8808
Published online Sep 6, 2022. doi: 10.12998/wjcc.v10.i25.8808
Ref. | Country | Date | Number of cases | Symptoms | Vaccine |
Colella et al[49] | Italy | February 2021 | 1 | Left Bell’s palsy | First dose of Pfizer |
Repajic et al[50] | United States | February 2021 | 1 | Left Bell’s palsy | Second dose of Pfizer |
Konstantinidis et al[25] | Greece Germany | May 2021 | 2 | Hyposmia | Second dose of Pfizer |
Keir et al[51] | United States | June 2021 | 1 | Phantosmia | Second dose of Pfizer |
Lechien et al[52] | France Belgium Italy | September 2021 | 6 | Smell abnormalities (n = 5); taste abnormality (n = 1) | The first injection of AstraZeneca (n = 4); a second injection of Pfizer (n = 2) |
Wichova et al[53] | United States | October 2021 | 30 | Hearing loss (25), vertigo (5), dizziness (8), tinnitus (15) | Moderna (n = 18), Pfizer (n = 12) |
Jeong and Choi[54] | Korea | December 2021 | 3 | SSNHL | One case after Oxford-AstraZeneca, 2 cases after Pfizer |
- Citation: Al-Ani RM. Ear, nose, and throat manifestations of COVID-19 and its vaccines. World J Clin Cases 2022; 10(25): 8808-8815
- URL: https://www.wjgnet.com/2307-8960/full/v10/i25/8808.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i25.8808